Now there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers, Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use. It also supplies detailed discussions of the clinical investigations that support current understanding of the risks and benefits associated with the use of these drugs. Thorough references make the book useful to the novice as well as the experienced clinician.
Initial chapters focus on agents that are considered standard care:
angiotensin receptor antagonists
The discussion moves to agents currently under investigation:
Next, the authors consider some controversial drugs:
An insightful examination of pharmacogenetics considers:
how studies of the genetic profile of patients helps determine which patient populations are most likely to respond to a given class of drugs
the potential use of pharmacogenetics to tailor a pharmacologic regimen for maximum benefit and minimum risk
Multidrug pharmacy for heart failure therapy
An extremely helpful concluding chapter provides a roadmap of drugs with which to approach the patient with heart failure, along with an overview of the skills you need to use it most effectively. This straightforward, step-by-step algorithm will save you countless hours of research and help you make your prescribing decisions with confidence.
From the Back Cover
Heart failure is a devastating disease of epidemic proportions. Physicians are faced with an increasingly large choice of treatment options and questions including: how different genetic, racial and gender backgrounds can influence a patient’s response; how to monitor treatment once it has begun; and what side-effects can be expected from these agents.
Heart Failure: Pharmacologic Management is the essential guide for physicians working with these issues to optimise their use of pharmacologic therapy for patients with heart failure.
This extensively referenced text provides both the biologic and pathologic underpinning for the use of eachpharmacologic agent currently recommended, including the clinical investigations that have led to our understanding of the risks and benefits associated with the use of these drugs. In addition, this book reviews several areas, including vasopressin antagonists, that are under active investigation, but which are expected to prove fruitful in the therapy of patients with heart failure.
Heart Failure: Pharmacologic Management is written by individuals with extensive expertise within the field and is the only text to focus on pharmacologic therapy. It will assist the practitioner in easily making sense of the extensive number of treatment agents available and should be considered a vital contribution to your bookshelf.rapidshare.com Heart_Failure_Pharmacologic_Management.rar
| 2190 KB